HELP
Cybin Inc. Common Stock
NYSE MKT: HELP · HEALTHCARE · BIOTECHNOLOGY
$5.31
+8.15% today
Updated 2026-04-30
Market cap
$269.43M
P/E ratio
—
P/S ratio
16,436.36x
EPS (TTM)
$-4.30
Dividend yield
—
52W range
$4 – $10
Volume
1.3M
Cybin Inc. Common Stock (HELP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2814.00 | $-237026.00 | $-83785.00 | $-1384.00 | $-19.03M | $-45.21M | $-47.43M | $-68.91M | $-101.30M |
| Capital expenditures | $10000.00 | $10000.00 | $35000.00 | $0.00 | $231000.00 | $520000.00 | $3.31M | $710000.00 | $1.97M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $153.00 | $11.55M | $18.03M | $4.69M | $13.89M | $42.87M |
| Free cash flow | $-7186.00 | $-247026.00 | $-118785.00 | $-1384.00 | $-19.26M | $-45.73M | $-50.74M | $-69.62M | $-103.27M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |